Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
McKinsey
Fuji
Mallinckrodt
Johnson and Johnson
QuintilesIMS
Julphar
Healthtrust
Baxter

Generated: October 19, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: selegiline hydrochloride

« Back to Dashboard

SELEGILINE HYDROCHLORIDE

CASRN: 14611-52-0UNII:

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Dow
Cipla
Queensland Health
Merck
Fuji
Daiichi Sankyo
Deloitte
Mallinckrodt